Major Drugs - Orchard Park, NY, US
NeuroproteXeon is a late clinical-stage pharmaceutical company developing the proprietary use of xenon gas, delivered via a patented inhalation device, to protect against brain cell death following acute neurologic injury. NP is currently preparing for a Phase III Clinical Trial in Out of Hospital Cardiac Arrest (OHCA).
Outlook
WordPress.org
Google Font API
Microsoft Office 365
GoDaddy Hosting
Google Analytics